Kevin Erreger, PhD
Affiliations: | Molecular Physiology & Biophysics | Vanderbilt University, Nashville, TN |
Area:
Dopamine Transporter and ReceptorsGoogle:
"Kevin Erreger"Mean distance: 15.03 (cluster 11) | S | N | B | C | P |
Cross-listing: Neurotree
Parents
Sign in to add mentor| Stephen F. Traynelis | grad student | Emory (Neurotree) | ||
| Stephen F. Traynelis | grad student | 2004 | Emory (Neurotree) | |
| (NMDA channel gating and modulation by zinc.) | ||||
| Aurelio Galli | post-doc | Vanderbilt | ||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Herborg F, Jensen KL, Tolstoy S, et al. (2021) Dominant-negative actions of a dopamine transporter variant identified in patients with parkinsonism and neuropsychiatric disease. Jci Insight |
| Campbell NG, Shekar A, Aguilar JI, et al. (2019) Structural, functional, and behavioral insights of dopamine dysfunction revealed by a deletion in . Proceedings of the National Academy of Sciences of the United States of America |
| Reddy IA, Smith NK, Erreger K, et al. (2018) Bile diversion, a bariatric surgery, and bile acid signaling reduce central cocaine reward. Plos Biology. 16: e2006682 |
| Reddy IA, Pino JA, Weikop P, et al. (2016) Glucagon-like peptide 1 receptor activation regulates cocaine actions and dopamine homeostasis in the lateral septum by decreasing arachidonic acid levels. Translational Psychiatry. 6: e809 |
| Ng J, Zhen J, Meyer E, et al. (2016) Novel therapeutic approaches for childhood parkinsonism The Lancet. 387: S77 |
| Dadalko OI, Siuta M, Poe A, et al. (2015) mTORC2/Rictor Signaling Disrupts Dopamine-Dependent Behaviors via Defects in Striatal Dopamine Neurotransmission. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 35: 8843-54 |
| Cartier E, Hamilton PJ, Belovich AN, et al. (2015) Rare autism-associated variants implicate syntaxin 1 (STX1 R26Q) phosphorylation and the dopamine transporter (hDAT R51W) in dopamine neurotransmission and behaviors. Ebiomedicine. 2: 135-146 |
| Hamilton PJ, Shekar A, Belovich AN, et al. (2015) Zn(2+) reverses functional deficits in a de novo dopamine transporter variant associated with autism spectrum disorder. Molecular Autism. 6: 8 |
| Bowton E, Saunders C, Reddy IA, et al. (2014) SLC6A3 coding variant Ala559Val found in two autism probands alters dopamine transporter function and trafficking. Translational Psychiatry. 4: e464 |
| Hansen FH, Skjørringe T, Yasmeen S, et al. (2014) Missense dopamine transporter mutations associate with adult parkinsonism and ADHD. The Journal of Clinical Investigation. 124: 3107-20 |